The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Launch of Indian public health standards for Ayush healthcare facilities
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
BHL will undertake the development and supply of these molecules
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Subscribe To Our Newsletter & Stay Updated
